Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CTE Global is a biotechnology company specializing in the development and supply of high-performance enzymes for the biofuels and distilling industries. The company provides a comprehensive portfolio of enzymatic solutions, including alpha-amylases, glucoamylases, and proteases, designed to optimize starch conversion and fermentation efficiency in ethanol production. Beyond product supply, CTE Global offers technical support and laboratory services to help plants maximize yield and reduce operational costs. Headquartered in Illinois, the firm serves as a key partner for industrial fermentation facilities seeking to improve process kinetics and overall plant profitability. Their specialized products also address viscosity reduction and nutrient release, supporting the production of high-quality co-products like distillers grains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CTE Global.